Definitive Contract 75F40124C00088
Award Date 8/5/24
Potential Completion Date 8/24/26
Potential Value $186K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
8(a) Sole Source
Extent Competed
Not Available for Competition
Major Defense Program
Not listed Pricing Type
Labor Hours
Place of Performance
St. Louis, MO 63110, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Food and Drug Administration awarded a direct 8(a) contract to Aneon Brillient, LLC, a minority-owned small disadvantaged business based in Reston, Virginia, for supply chain technical support services to the Center for Drug Evaluation and Research. This labor-hour contract has a base period of 9.5 months with two 12-month option periods, carrying a total ceiling value of $4.2 million and an ultimate completion date of June 15, 2028. Work will be performed in Beltsville, Maryland. As an...
- The Food and Drug Administration (FDA) awarded an 8(a) direct contract to Aneon Brillient, LLC on August 2, 2024, for professional services supporting the Center for Drug Evaluation and Research (CDER). The definitive labor-hour contract has a 12-month base period with a 9-month option and a total ceiling value of approximately $4.3 million. Work will be performed in Calverton, Maryland, with an ultimate completion date of May 31, 2026. This award was not set aside for small businesses but...
- The Food and Drug Administration awarded a Definitive Contract to Aneon Brillient, LLC on September 17, 2024, for shipping, receiving, printing support, and administrative support services to the Office of Regulatory Affairs' Office of Training, Education, and Development. This 8(a) sole source contract carries a ceiling value of $326.3K and is structured as a labor-hours engagement, with performance extending through September 29, 2026. The work will be performed in Reston, Virginia, where...
- The Food and Drug Administration (FDA) awarded an 8(a) sole source, stand-alone labor-hour contract to Aneon Brillient, LLC, a minority-owned, SBA-certified 8(a) joint venture based in Reston, Virginia, for professional services supporting the Oncology Center of Excellence. The contract, with a ceiling value of $1.9M, was awarded on August 12, 2026, and extends through August 11, 2027. Work will be performed in Silver Spring, Maryland. As a small disadvantaged business, Aneon Brillient leverages...
- This is a direct 8(a) award of a 12-month, labor-hour type contract to Aneon Brillient, LLC for the U.S. Food and Drug Administration's (FDA) Center for Drug Evaluation and Research (CDER) to provide professional services support. The contract has a ceiling value of $3,266,346.36 and does not utilize a set-aside. Aneon Brillient is a minority-owned, small disadvantaged business registered as an 8(a) joint venture that specializes in providing a range of professional services to the FDA,...
- This is a direct 8(a) award of a 4-year, labor-hour type contract to Aneon Brillient, LLC to provide medical and scientific writing and editing services for the U.S. Food and Drug Administration's (FDA) Center for Drug Evaluation and Research (CDER). The contract has a ceiling value of $2,133,514.80. Aneon Brillient is a minority-owned, small disadvantaged business certified as an SBA 8(a) joint venture located in Reston, Virginia. The company specializes in providing professional services to...
- This is a direct 8(a) sole source, labor-hour type contract awarded by the Food and Drug Administration (FDA) to Aneon Brillient, LLC, a minority-owned, small disadvantaged business certified as an 8(a) joint venture. The contract is for professional services to support the FDA's Oncology Center of Excellence, with an ultimate completion date of August 11, 2026 and a ceiling value of $2,220,109.12. Aneon Brillient, LLC specializes in providing a variety of professional services to the FDA,...
- The U.S. Food and Drug Administration (FDA) has awarded a single-award, labor-hour (LH) contract to Aneon Brillient, LLC, an SBA certified 8(a) joint venture small disadvantaged business, to provide Freedom of Information Act (FOIA) support services for the FDA's Center for Biologics Evaluation and Research (CBER). This $1,479,584.76 ceiling value contract is a direct 8(a) sole source award with a period of performance through August 27, 2025. Aneon Brillient, a minority-owned limited...
- This is a $144,964.92 sole source 8(a) contract awarded by the Food and Drug Administration (FDA) to Aneon Brillient, LLC, a minority-owned small disadvantaged business. The contract is for additive manufacturing of medical products core facility support, on a labor-hour basis. Aneon Brillient is an SBA-certified 8(a) joint venture that specializes in providing professional services to the FDA, including across the Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation...
- The Food and Drug Administration (FDA) awarded a definitive contract to Aneon Brillient, LLC on February 28, 2024, to provide transcription services supporting the Center for Drug Evaluation and Research (CDER) Advisory Committee meetings. The contract, set aside as an 8(a) sole source award, carries a ceiling value of approximately $642.5K and extends through February 27, 2027. Under this labor-hour contract, Aneon Brillient will deliver transcription services and support materials necessary...